ArriVent BioPharma Ownership | Who Owns ArriVent BioPharma?


OverviewForecastFinancialsChart

ArriVent BioPharma Ownership Summary


ArriVent BioPharma is owned by 102.92% institutional investors, 1.54% insiders. Suvretta capital management is the largest institutional shareholder, holding 10.02% of AVBP shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 5.47% of its assets in ArriVent BioPharma shares.

AVBP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockArriVent BioPharma102.92%1.54%-4.46%
SectorHealthcare Stocks 50.59%12.40%37.01%
IndustryBiotech Stocks 49.10%12.14%38.76%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Suvretta capital management4.52M10.02%$156.87M
Infinitum asset management4.44M9.85%$154.19M
Hhlr advisors3.93M8.72%$136.50M
Blackrock funding, inc. /de3.25M7.21%$112.92M
Orbimed advisors3.03M6.72%$105.17M
Fmr2.78M6.17%$96.54M
Vanguard group1.87M4.46%$37.61M
Octagon capital advisors lp1.97M4.37%$68.47M
Vanguard capital management1.77M3.94%$61.66M
Sofinnova investments1.70M3.76%$58.95M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
General catalyst group management1.49M27.55%$51.93M
Hhlr advisors3.93M16.40%$136.50M
Infinitum asset management4.44M15.68%$154.19M
Octagon capital advisors lp1.97M6.15%$68.47M
Vivo capital1.68M5.34%$58.44M
Acuta capital partners218.69K5.29%$7.60M
Sofinnova investments1.70M3.05%$58.95M
Novo1.50M3.03%$52.11M
Suvretta capital management4.52M2.87%$156.87M
Orbimed advisors3.03M1.96%$105.17M

Top Buyers

HolderShares% AssetsChange
Vivo capital1.68M5.34%796.18K
Blackrock funding, inc. /de3.25M0.00%720.10K
Logos global management lp1.00M1.50%650.00K
D. e. shaw872.01K0.01%503.22K
Foresite capital management vi301.34K1.63%301.34K

Top Sellers

HolderShares% AssetsChange
Siren---700.00K
Cormorant asset management, lp---585.46K
Fund 1 investments---499.99K
Novo1.50M3.03%-442.14K
Franklin resources---256.42K

New Positions

HolderShares% AssetsChangeValue
Foresite capital management vi301.34K1.63%301.34K$10.47M
Sixth street partners management company294.22K0.00%294.22K$10.22M
Acuta capital partners218.69K5.29%218.69K$7.60M
Trexquant investment lp71.86K0.01%71.86K$2.50M
Toroso investments57.03K0.00%57.03K$1.98M

Sold Out

HolderChange
Ifp advisors-1.00
True wealth design-6.00
Montag a & associates-11.00
Principal securities-16.00
Root financial partners-18.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202616413.10%46,382,3799.91%1020.85%11220.43%28-
Mar 31, 202614318.18%42,190,2885.19%1091.20%9126.39%28-17.65%
Dec 31, 202580-25.23%13,197,905-65.78%310.37%46-26.98%2531.58%
Sep 30, 20251058.25%38,570,31714.70%1101.19%6326.00%18-40.00%
Jun 30, 20259615.66%33,618,96315.59%961.30%498.89%3042.86%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
HBM Healthcare Investments AG Ord2.55M5.47%-
Fidelity Select Biotechnology1.39M2.98%-50.90K
Vanguard Total Stock Mkt Idx Inv1.34M2.87%183.50K
Vanguard Morn Total Stk Mkt Idx Investor1.34M2.87%183.50K
Vanguard MStar Total Stk Mkt Idx Invest1.34M2.77%-
iShares Russell 2000 ETF963.43K2.07%-17.09K
State Street® SPDR® S&P® Biotech ETF863.60K1.85%1.98K
Fidelity Growth Compy Commingled Pl S448.93K0.96%-
Vanguard Institutional Extnd Mkt Idx Tr397.75K0.82%794.00
iShares Russell 2000 Growth ETF341.51K0.73%-3.13K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 10, 2025HILLHOUSE INVESTMENT MANAGEMENT, LTD.-Sell$12.98M
Jan 30, 2024HILLHOUSE INVESTMENT MANAGEMENT, LTD.-Buy$10.00M
Jan 30, 2024ORBIMED ADVISORS LLC Buy$4.00M
Jan 30, 2024GORDON CARL L Buy$4.00M
Jan 30, 2024HEALY JAMES-Buy$8.00M

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4-1
2025 Q3--
2025 Q2--
2024 Q14-

AVBP Ownership FAQ


Who Owns ArriVent BioPharma?

ArriVent BioPharma shareholders are primarily institutional investors at 102.92%, followed by 1.54% insiders and -4.46% retail investors. The average institutional ownership in ArriVent BioPharma's industry, Biotech Stocks , is 49.10%, which ArriVent BioPharma exceeds.

Who owns the most shares of ArriVent BioPharma?

ArriVent BioPharma’s largest shareholders are Suvretta capital management (4.52M shares, 10.02%), Infinitum asset management (4.44M shares, 9.85%), and Hhlr advisors (3.93M shares, 8.72%). Together, they hold 28.59% of ArriVent BioPharma’s total shares outstanding.

Does Blackrock own ArriVent BioPharma?

BlackRock is not among the top 10 institutional shareholders of ArriVent BioPharma.

Who is ArriVent BioPharma’s biggest shareholder by percentage of total assets invested?

General catalyst group management is ArriVent BioPharma’s biggest shareholder by percentage of total assets invested, with 27.55% of its assets in 1.49M ArriVent BioPharma shares, valued at 51.93M$.

Who is the top mutual fund holder of ArriVent BioPharma shares?

HBM Healthcare Investments AG Ord is the top mutual fund holder of ArriVent BioPharma shares, with 5.47% of its total shares outstanding invested in 2.55M ArriVent BioPharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools